On 27 October 2021, SKAN Group AG, a global market leader in high-quality isolator systems for aseptic production processes in the (bio)pharmaceutical industry, announced the pricing of its IPO, consisting of 1,731,494 newly issued shares and 2,768,506 existing shares and an over-allotment option of up to 500,000 shares, at CHF 54 per share, implying a total market capitalization of CHF 1.214 billion. SKAN’s shares started trading on SIX Swiss Exchange on 28 October 2021.